Matteo Mauceri
Overview
Explore the profile of Matteo Mauceri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scattolin T, Cavarzerani E, Alessi D, Mauceri M, Botter E, Tonon G, et al.
Dalton Trans
. 2025 Feb;
54(11):4685-4696.
PMID: 39967474
High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations. Typically diagnosed at an advanced stage,...
2.
Bortolamiol E, Mauceri M, Piccolo R, Cavarzerani E, Demitri N, Donati C, et al.
J Med Chem
. 2024 Aug;
67(16):14414-14431.
PMID: 39119630
In this study, we synthesized novel Pd(II)-indenyl complexes using various -heterocyclic carbene (NHC) ligands, including chelating NHC-picolyl, NHC-thioether, and diNHC ligands, and two monodentate NHCs. Transmetalation reactions between a Pd(II)-indenyl...
3.
Tonon G, Mauceri M, Cavarzerani E, Piccolo R, Santo C, Demitri N, et al.
Dalton Trans
. 2024 Apr;
53(19):8463-8477.
PMID: 38686752
In continuation of our previous works on the cytotoxic properties of organopalladium compounds, in this contribution we describe the first systematic study of the anticancer activity of Pd(II)-aryl complexes. To...
4.
Bortolamiol E, Botter E, Cavarzerani E, Mauceri M, Demitri N, Rizzolio F, et al.
Molecules
. 2024 Jan;
29(2).
PMID: 38257258
A new class of palladium-indenyl complexes characterized by the presence of one bulky alkyl isocyanide and one aryl phosphine serving as ancillary ligands has been prepared, presenting high yields and...
5.
Palazzolo S, Caligiuri I, Sfriso A, Mauceri M, Rotondo R, Campagnol D, et al.
Toxics
. 2022 Feb;
10(2).
PMID: 35202277
Short-chain per-fluoroalkyl substances (PFAS) have replaced long-chains in many applications, however the toxicity and its mode of action and interactions due to the large number of these compounds and their...
6.
Poli G, Di Stefano M, Estevez J, Minutolo F, Granchi C, Giordano A, et al.
J Enzyme Inhib Med Chem
. 2021 Dec;
37(1):145-150.
PMID: 34894990
PIN1 is considered as a therapeutic target for a wide variety of tumours. However, most of known inhibitors are devoid of cellular activity despite their good enzyme inhibitory profile. Hence,...
7.
Adeel M, Parisi S, Mauceri M, Asif K, Bartoletti M, Puglisi F, et al.
ACS Omega
. 2021 Nov;
6(43):28611-28619.
PMID: 34746556
High-grade serous ovarian cancer (HGSOC) is one of the major life-threatening cancers in women, with a survival rate of less than 50%. So far, chemotherapy is the main therapeutic tool...
8.
Trevisan G, Vitali V, Tubaro C, Graiff C, Marchenko A, Koidan G, et al.
Dalton Trans
. 2021 Sep;
50(38):13554-13560.
PMID: 34505859
A small library of dinuclear gold(I) complexes with the title ligands has been prepared, encompassing neutral, mono- and dicationic complexes. The luminescence properties of the complexes in the solid state...